Table 1. Sociodemographic and clinical characteristics.
| Variable | non-PTSD(n = 35) | PTSD(n = 42) | p |
| Agea (years) | 29.1±9.7 | 32.6±9.1 | 0.11 |
| Gender (Female/Male) | 22/13 | 21/21 | 0.26 |
| Region of origin (%) | 0.59 | ||
| Africa | 28.6 | 28.6 | |
| Balkan | 17.1 | 9.5 | |
| Middle East/Afghanistan | 54.3 | 61.9 | |
| Psychotropicmedication (%) | <0.001 | ||
| Hypnotics | 0 | 14.3 | |
| Anxiolytics | 0 | 11.9 | |
| Antidepressants | 0 | 28.6 | |
| Neuroleptics | 0 | 7.1 | |
| Contraceptives (%) | 17.1 | 9.5 | 0.64 |
| Smoking (%) | 14.3 | 28.6 | 0.13 |
| Cigarettes per day a | 0.8±2.4 | 5.7±11.4 | <0.01 |
| Number of traumaticevent typesa | |||
| War or torture events | 1.8±4.4 | 10.4±5.8 | <0.001 |
| CAPS events | 3.5±2.3 | 7.4±2.0 | <0.001 |
| CAPS scorea | 3.7±8.0 | 84.2±17.3 | <0.001 |
| HAM-D scorea | 2.9±3.5 | 27.1±8.3 | <0.001 |
| SOMS-7 scorea | 5.0±6.7 | 29.2±12.5 | <0.001 |
a
Data are presented as mean ± SD. Group differences were analyzed using chi-square tests (categorical data) and t-tests (continuous data). CAPS, Clinician Administered PTSD Scale; HAM-D, Hamilton Depression Rating Scale; SOMS-7, Screening for Somatoform Symptoms-7.